Skip to main content
Clinical Trials/NCT04945837
NCT04945837
Not yet recruiting
Not Applicable

Psychologic Impact of COVID-19 Pandemic on the Hospital Staff of the Nouvelle Aquitaine Area : a Prospective Longitudinal Study by Self-administered Questionnaires

Centre Hospitalier Charles Perrens, Bordeaux0 sites8,000 target enrollmentSeptember 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Covid19
Sponsor
Centre Hospitalier Charles Perrens, Bordeaux
Enrollment
8000
Primary Endpoint
Changes in anxiety disorder overcome
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

Evaluation of the psychological impact of the COVID-19 pandemic on hospital staff in the French Nouvelle Aquitaine area, through a longitudinal study with repeated self-administered psychologic scales

Detailed Description

Evaluation of the psychological impact of Coronavirus disease 2019 (COVID-19) on hospital personnel in Nouvelle Aquitaine. IMPSY-COV Upon recent outbreaks of new diseases (SARS, MERS-CoV, Ebola) have led to the emergence of psychiatric disorders in healthcare workers , such as post-traumatic stress , anxiety (e.g., panic attacks) or depressive episodes. Observed similarities in between propagation patterns of SARS-CoV-2 and SARS, alow us to expect the occurence of similar psychiatric disorders in COVID-19 context to those described (Vignaud, Prieto, 2020). The study is set up to assess the psychological state of hospital personnel in the working conditions of treating COVID-19 suffering patients. 87000 hospital staff workers from the Nouvelle Aquitaine region will be invited to take part in the study. This includes medical and non-medical professionals from general and psychiatric hospitals exposed to COVID-19. Study design. The protocol shows two phases and five measurement timepoints. In the initial phase (T0), eligible persons will be contacted via email. Those wishing to participate will then consent, answer socio-demographic questions and a series of psychology questionnaires. In the longitudinal phase, participants will be again invited to answer the same series of questionnaires four times: one month after the initial phase (T1), 3 months after (T2), 6 months after (T3) and 12 months after (T4). Statistical analysis. In order to identify the consequences generated by COVID-19 in hospital personnel through a longitudinal protocol, several statistical analyses are considered, including logistic and linear regressions as well as ANOVA and MANOVA. Expected outcomes. The study will assess the occurrence and the evolution of psychological distress and identify vulnerability factors that may trigger psychiatric disorders in these situations. The study will also provide an opportunity to improve the supporting actions of professionals affected by the crisis.

Registry
clinicaltrials.gov
Start Date
September 2022
End Date
December 2024
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Centre Hospitalier Charles Perrens, Bordeaux
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 18 years or more
  • hospital workers exposed to COVID-19
  • consented to participate to the study
  • master the french langage
  • Understanding of type, objectives and study methology
  • accept an on-line evaluation
  • Benefit from health insurance

Exclusion Criteria

  • refuse to participate
  • pregnant or breastfeeding woman
  • Be under measure of legal protection: guardianship, curatorship or safeguard of justice.

Outcomes

Primary Outcomes

Changes in anxiety disorder overcome

Time Frame: inclusion, month 1, month 3, month 6, month 12

PDSR verifies that maximum of the panic state is reached within ten minutes

Secondary Outcomes

  • Determination and collection of lived traumatic events types(inclusion, month 1, month 3, month 6, month 12)
  • Burn out diagnosis(inclusion, month 1, month 3, month 6, month 12)
  • Evaluation of the CUMP support to health professionnals(inclusion, month 1, month 3, month 6, month 12)
  • Posttraumatic stress disorder symptoms presence and measurment(inclusion, month 1, month 3, month 6, month 12)
  • 2-last-week mood assessment(inclusion, month 1, month 3, month 6, month 12)
  • Self evaluation of state of health(inclusion, month 1, month 3, month 6, month 12)
  • Identification of coping pattern to stress(inclusion, month 1, month 3, month 6, month 12)
  • Psycho active drugs intakes and level of intake over the last month(inclusion, month 1, month 3, month 6, month 12)

Similar Trials